MRKR
Marker Therapeutics (MRKR)
$80
About Marker Therapeutics (MRKR)
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of novel cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company was founded on October 22, 1991 and is headquartered in Houston, TX.
Details
Daily high
$2.93
Daily low
$2.66
Price at open
$2.66
52 Week High
$6.16
52 Week Low
$2.40
Market cap
25.0M
Dividend yield
0.00%
Volume
8,318
Avg. volume
27,548
P/E ratio
-2.41
Marker Therapeutics News
Details
Daily high
$2.93
Daily low
$2.66
Price at open
$2.66
52 Week High
$6.16
52 Week Low
$2.40
Market cap
25.0M
Dividend yield
0.00%
Volume
8,318
Avg. volume
27,548
P/E ratio
-2.41